PsiThera
Pre-clinicalPsiThera is advancing programs across multiple targets from the TNF superfamily and beyond, where no oral therapies currently exist.
Founded
2018
Focus
Small Molecules
About
PsiThera is advancing programs across multiple targets from the TNF superfamily and beyond, where no oral therapies currently exist.
Funding History
2Total raised: $36M
Series A$28MSofinnova PartnersApr 15, 2022
Seed$8MUndisclosedNov 15, 2020
Company Info
TypePrivate
Founded2018
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile